Annual Report 2007
Multiple Myeloma Research Foundation
Mission
Statement
The mission of the
Multiple Myeloma Research
Foundation (MMRF) is to
urgently and aggressively
fund research that will
lead to the development
of new treatments and a
cure for multiple myeloma.
A b o u t
t h e
MMRF
The Multiple Myeloma
Research Foundation
(MMRF) was founded
in 1998 by identical
twin sisters Kathy Giusti
and Karen Andrews
shortly following Kathy’s
MMRF Co-Founders Kathy Giusti
diagnosis with multiple and Karen Andrews
myeloma, an incurable blood cancer. It was
their goal to raise critical research funds that
would lead to the development of new
myeloma treatments and, ultimately, a cure.
As a patient-focused organization, the MMRF
is driven by the same sense of urgency and
immediacy that myeloma patients face daily.
Having raised more than $90 million to date,
the MMRF is the driving force behind
progress made against the disease and one
of the nation’s most groundbreaking cancer
research organizations.
Dear Friends,
You have been a source of vital support for the Multiple Myeloma
Research Foundation (MMRF) and we thank you for making this an
extraordinary year. Thanks to your generosity, we have made significant
progress and have reached several important milestones:
■ FDA approval of Doxil, the fourth treatment option we have helped
bring to patients in the last four years;
■ Seven new clinical trials launched through our sister organization, the
Multiple Myeloma Research Consortium (MMRC);
■ Thirty additional compounds currently under investigation; and
■ A remarkable increase in life expectancy from four years to almost
seven years.
We are proud of these successes, but against this backdrop of progress is the stark reminder
that myeloma remains an incurable disease, and many patients have run out of options. We
are doing everything we can to advance the next generation of treatments, but we cannot
do it alone. Private philanthropy will continue to drive our progress.
This year, a decrease in the budget of the National Cancer Institute was authorized for the
second consecutive year and, as a result of this cut, the number of research grants funded
has rapidly diminished. That is why, in the year to come, your renewed and dedicated
support is more critical than ever.
On behalf of the MMRF and the many patients and families living with multiple myeloma,
please accept my heartfelt gratitude once again for your kindness and generosity and for
making this amazing year possible.
Sincerely,
Kathy Giusti
Founder and Chief Executive Officer
3
MMRF Annual Report 2007
Report from the
Chief Operating Officer
As a good steward of your donation, the Multiple Myeloma Research Foundation (MMRF)
directs an outstanding 93 percent of contributions toward research and related programming.
The MMRF has consistently earned top rankings from the nation’s leading charity evaluators
for its fiscal responsibility.
Dear Friends,
As one the most efficient and effective charities
worldwide, the Multiple Myeloma Research Foundation
(MMRF) directs an outstanding 93 percent of all funds
raised toward our portfolio of high-impact, far-reaching
research initiatives and related programming. This year,
our exceptional financial management resulted in us
reaching several important milestones, including:
2007 Allocation of
MMRF Funds
4% Fundraising
3%
Administrative
Costs
Scott Santarella
COO and Executive Director
■ Fifty percent growth, bringing our total funds raised to
more than $90 million
■ Awarding $13 million in research grants and funding
■ Earning a 4-star rating from Charity Navigator for the fifth
consecutive year, a ranking that places us among the top
three percent of all charities
93% Research Awards
and Related Programming
■ “Best in America” Seal of Excellence from the Independent Charities of America
■ A 4-star rating from Charity Navigator
We are grateful for support from generous donors like you, who help bridge
critical funding gaps and enable us to rapidly and aggressively advance our
research portfolio.
■ An A+ from the American Institute of Philanthropy
Thank you for being part of our team.
■ Approval from the National Cancer Institute (NCI) for our research grants program
Scott Santarella
COO and Executive Director
4
Exceptional
Financial Management
■ Complies with the Better Business Bureau’s (BBB) Wise Giving Alliance Standards for
Charity Accountability
The MMRF is the world’s only organization to have received these exceptional
accreditations.
5
MMRF Annual Report 2007
Delivering
Treatments to Patients
“The MMRF’s business
approach to science means they
demand results on a timeline of
When the Multiple Myeloma Research Foundation (MMRF) was founded in 1998, there were
few available treatment options, an empty pipeline, and minimal research investment. With
your support and generosity, the MMRF has worked hard to change that environment, and
the results of our efforts have been significant.
In 2007, the MMRF celebrated the FDA approval of Doxil, the fourth new drug we have
helped bring to patients in the past four years. Remarkably, with more treatment options
available than ever before, and 30 more compounds and combination approaches in clinical
trials or pre-clinical studies, life expectancy for myeloma patients has increased from four years
to almost seven years.
Myeloma Drugs Approved
months, not years. And they have
the track record to prove it.”
2003
2004
2005
2006
2007
Velcade®
FDA approved
2003
40%
1992
28.8%
Thalomid®
FDA approved
2006
20%
Revlimid®
FDA approved
2006
2004
17.4%
Doxil®
FDA approved
2007
10%
1992
11.1%
5-year
survival
rate
Unprecedented success: four treatments in four years when it
usually takes 10 years for one treatment to get FDA approval.
6
7
$
B
$
2004
34.7%
30%
— Lance Armstrong, Chairman and Founder
Lance Armstrong Foundation
m Multiple
u lt i p l e m
yeloma
Myeloma
Survival
s u r v i va l
myeloma
drugs FDA
approved
by the fda 2003–2007
by the
2003-2007
10-year
survival
rate
MMRF Annual Report 2007
Funding an
Innovative Research Portfolio
Guided by an innovative scientific plan, the Multiple Myeloma Research Foundation (MMRF)
supports one of the world’s most strategic and aggressive research and drug development
portfolios. And, with a payline that averages 30 percent, it is also one of the most responsive.
“With their commitment
to innovation, speed, and results, the
The MMRF’s research and drug development portfolio is comprised of cutting-edge
programs in three paths — basic science, validation, and clinical trials — that represent our
long-, mid-, and short-term strategy to drive the development of better, more effective
treatments and, ultimately, find a cure.
In 2007, the MMRF directed $13 million into these efforts.
MMRF and MMRC now serve as
Basic Science
a model for other organizations
In the long-term, the MMRF supports basic science research to identify new molecular
targets for myeloma and to develop a better understanding of myeloma as the first step in
developing better, more effective treatments for the disease. In 2007, the MMRF invested
in this research path through several different grants programs, including:
seeking to deliver new treatments
to patients.”
— Robert J. Beall, PhD, President and CEO
Cystic Fibrosis Foundation
■ The Multiple Myeloma Genomics Initiative
The MMRF awarded the MMRC a grant to advance the cutting-edge Multiple
Myeloma Genomics Initiative, a comprehensive genome-mapping program, conducted
in partnership with the Translational Genomics Research Institute (TGen) and the
Eli and Edythe L. Broad Institute.
■ The Multiple Myeloma Proteomics Initiative
The MMRF awarded a grant to the University of Arkansas for Medical Sciences,
Indiana University, and the University of Michigan through the Proteomics
Initiative, a cutting-edge research program developed to identify new biomarkers
and potential therapeutic targets in myeloma.
■ MMRF Fellows Awards
Matthew Drake, MD, PhD
Mayo Clinic, Rochester
Igor Entin, PhD
University of Arkansas
for Medical Sciences
Francesca Fiore, MD
University of Turin, Italy
Jonathan Keats, PhD
Mayo Clinic, Arizona
8
Juntao Luo, PhD
University of California, Davis
Attaya Suvannasankha, MD
Indiana University
Sridevi Ponduru, MD, PhD
Dana-Farber Cancer Institute
Rodger Tiedemann, MD, PhD
Mayo Clinic, Arizona
Toshiki Saito, MD, PhD
Massachusetts General Hospital
Xiangao Huang, PhD
Weill Medical College of
Cornell University
James Stewart, PhD
University of Arkansas
for Medical Sciences
9
MMRF Annual Report 2007
Funding an Innovative
Research Portfolio
Validation
“I know my contribution
to the MMRF will support
breakthrough research that
will help myeloma patients
live longer, better lives.”
— Avi Noar
Avi Noar, whose son-in-law
had multiple myeloma, has
donated more than $2 million
to MMRF. As a businessman,
Naor was impressed by the
M M R F ’s b u s i n e s s m o d e l
of setting goals, strictly
adhering to those goals,
and using the majority
of donations to support
research that will lead to
tratment innovations and,
one day, a cure.
In the mid-term, the MMRF supports research aimed at the
identification and prioritization of compounds and combination
approaches with the most potential in treating myeloma.
In 2007, the MMRF invested in this research path through
several different grants programs, including:
■ Validation of Novel Compounds and
Combinations Awards
Attaya Suvannasankha, MD Karin Vanderkerken, PhD
Indiana University
Free University of Brussels
Steven Grant, MD
Virginia Commonwealth
University
■ Senior Research Awards
Leif Bergsagel, MD
Mayo Clinic, Arizona
Yulia Nefedova, PhD
H. Lee Moffitt Cancer Center
Erik Nelson, PhD
Dana-Farber Cancer Institute
Ruben Carrasco, MD
Dana-Farber Cancer Institute
Michele Pagano, MD
New York University
Selina Chen-Kiang, PhD
Weill Cornell University
Aaron Schimmer, MD, PhD
University Health Network
Lionel Coignet, PhD
Roswell Park Cancer Institute
Megan Sykes, MD
Massachusetts General
Hospital
Shaji Kumar, MD
Mayo Clinic, Rochester
In the short-term, the MMRF supports Phase I and Phase II
clinical trials of the most promising compounds and
combinations active against high-priority myeloma targets.
MMRF-supported clinical trials are designed to include
correlative science studies to better understand what drugs
are most effective in treating various sub-groups of myeloma
patients, laying the foundation for the eventual development
of personalized medicines as a treatment for myeloma.
In 2007, the MMRF invested in this research path through
several different grants programs, including:
“We’ve placed our bet on
what we believe to be a
winning organization.”
—Stephen Grand
■ Biotech Investment Awards
Stephen Grand, a myeloma
Serenex, Inc.
Bjarne Bogen, PhD
University of Oslo
Teru Hideshima, MD
Dana-Farber Cancer Institute
Clinical Trials
Acceleron Pharma, Inc.
patient, joined the MMRF
MannKind Corporation
Board of Directors in 2006.
Steve and his wife, Nancy, are
also among the MMRF’s most
■ Multiple Myeloma Research Consortium
In 2007, the MMRF supported the launch of
seven clinical trials of novel and combination
treatments through its sister organization, the
Multiple Myeloma Research Consortium (MMRC).
Committed to bringing new treatments to patients as
quickly as possible, the MMRC focuses on advancing
promising therapies out of the research lab and into
early clinical trials (see page 12).
generous and committed
investors. In 2007, the Grands
contributed $6 million to
fund the MMRF’s innovative
research portfolio.
Yang Yang, MD, PhD
University of Alabama,
Birmingham
■ Animal Model Development Awards
Preet Chaudhary, MD, PhD Marxa Figueiredo, PhD
University of Pittsburgh
University of California,
Los Angeles
Yaoqi Wang, PhD
10
Dana-Farber Cancer Institute
11
MMRF Annual Report 2007
Funding
the MMRC
The mission of the Multiple Myeloma Research Consortium (MMRC)
is to accelerate the development of novel and combination treatments
“The MMRF and MMRC
for patients with multiple myeloma by facilitating innovative clinical trials
are providing an end
and correlative studies.
MMRC Member Institutions
to end solution for
Dana-Farber Cancer Institute
As an extension of its mission, Multiple Myeloma Research Foundation (MMRF) proudly
supports its sister organization, the Multiple Myeloma Research Consortium (MMRC).
The MMRC facilitates high-quality Phase I and Phase II clinical trials of promising novel
compounds and combination approaches.
MMRC clinical trials are designed to include associated correlative science studies. By
correlating patient tissue samples with clinical trial data, MMRC researchers are improving
their understanding of which drugs are most effective in treating various sub-groups of
myeloma patients and laying the foundation for the eventual development of personalized
medicine as a treatment for myeloma.
In 2007, the MMRF supported the MMRC in advancing several exciting research and drug
development efforts, including the initiation of seven clinical trials of novel compounds and
combinations and associated correlative science studies.
Clinical Trials
companies like ours,
H. Lee Moffitt Cancer Center & Research Institute
from pre-clinical to the
Mayo Clinic Cancer Center
City of Hope National Medical Center
clinical development
Emory University
plan, bringing new
Hackensack University Medical Center
Indiana University Simon Cancer Center
and innovative drugs
Ohio State University Comprehensive Cancer Center
to market.”
Roswell Park Cancer Institute
Saint Vincent Catholic Medical Centers of New York
University Health Network (Princess Margaret Hospital)
— Peter Sportelli, Director
University of California, San Francisco
of Oncology Development,
University of Chicago
■ Phase II Novartis LBH589
University of Michigan
■ Phase I Ortho Tipifarnib-Velcade (with correlative science studies)
Washington University
Keryx Pharmaceuticals
■ Phase I/II Wyeth Torisel-Velcade (with correlative science studies)
■ Phase II Proteolix Carfilzomib (relapsed/refractory)
■ Phase II Proteolix Carfilzomib (relapsed)
■ Phase I Semafore SF1126 (with correlative science studies)
■ Phase Ib Novartis LBH589-Velcade
12
13
MMRF Annual Report 2007
Building
Collaborations
Multiple Myeloma Research Foundation (MMRF) Research Roundtables bring together
an extraordinary assembly of academic researchers, scientists from the biotech and
pharmaceutical industries, technology pioneers, and representatives from the National
Institutes of Health (NIH). These dynamic events promote a collaborative approach to
addressing critical barriers and opportunities in developing new and combination treatments
for multiple myeloma. In 2007, the MMRF convened several Research Roundtables, including:
Combination Strategies in the Treatment of Multiple Myeloma
Jan. 29-30, 2007
Tampa, Florida
This innovative Roundtable brought together top myeloma researchers to develop new strategies for
combining novel therapies, such as Velcade® (bortezomib) and Revlimid® (lenalidomide), with other
novel and currently available agents as treatments for multiple myeloma. Roundtable participants
met the charge of determining the biological rationale for combining these therapies, identifying
optimal strategies for testing these combinations in the laboratory, and designing clinical trials of
drug combinations.
Scientific Agenda Research Roundtable
March 5, 2007
New York, NY
The MMRF updated its cutting-edge research plan at the 2007 Scientific Agenda Research
Roundtable. Roundtable participants identified several high-impact programs, including a focus on
proteomics, imaging, and the development of new validation models, which will guide the MMRF
and MMRC as they continue to advance their research strategy.
Top Therapeutic Targets for Multiple Myeloma
Sept. 10, 2007
New York, NY
This exciting Roundtable brought together more than 25 biotech companies with leading myeloma
researchers to determine how compounds in the companies’ pipelines could be applied to myeloma
and to explore collaborations to develop combination therapies. Several companies that attended the
Roundtable are now collaborating with the MMRF to bring promising compounds and combination
approaches to myeloma patients.
14
Educating the
Myeloma Community
The Multiple Myeloma Research Foundation (MMRF) is committed to educating and informing
patients and their families, as well as clinicians and researchers, with the most up-to-date
information on myeloma research. All MMRF educational services are available free of charge.
MMRF Patient Navigator Program
In 2007, the MMRF launched the MMRF Patient Navigator Program, a
highly-personalized service that enables patients to learn about new
therapies and find a clinical trial that best matches their needs. This
important resource can be accessed through the MMRF’s website or
by calling a toll-free number: 1-866-603-MMCT.
Website
In 2007, more than 700,000 people visited the MMRF’s website,
www.multiplemyeloma.org. This dynamic site provides visitors with
information on everything they need to know about myeloma — from
research updates to help finding a clinical trial. The website also
hosts webcasts from major medical meetings, as well footage from
teleconferences with research experts.
Educational Symposia and Workshops
In 2007, the MMRF was selected following a highly competitive
process to present educational symposia at several national
and international workshops and meetings, including the
Oncology Nursing Society Annual Congress, the American Society of
Hematology’s Annual Meeting and Exposition, and the American
Society of Clinical Oncology Annual Meeting, where it was the only
foundation selected to present.
Newsletters
In 2007, more than 15,000 people received MMRF SmartBrief, a
weekly email newsletter highlighting the latest scientific research and
clinical trials, and nearly 250,000 people received Myeloma Focus, a
quarterly print newsletter.
15
MMRF Annual Report 2007
Communicating
Our Innovative Model
“The MMRF uses a model
that all research groups
should involve, including
accountability and efficient
use of resources.”
In 2007, the Multiple Myeloma Research Foundation
(MMRF) received widespread coverage in prominent media
outlets of its important work in breaking down barriers to cancer
research and drug development. Major publications, such as
NBC Nightly News, CenterWatch, and PharmaVoice, featured
the MMRF’s innovative approach to funding myeloma research
and bringing to treatments to patients.
Sharing
Our Knowledge
The MMRF was also invited to present at several national and international think tanks and
summits, including the Biotechnology Industry Organization (BIO) International Convention,
Health Research Alliance (HRA) National Conference, Milken Global Conference, and
the TransMed Partnership Forum. MMRF leadership was called upon to discuss the MMRF’s
efforts in developing solutions to barriers slowing cancer research and drug development,
including the development of the MMRF’s strategic research portfolio and the development
of a cutting-edge tissue bank.
In 2007, the MMRF also proudly participated in Lance Armstrong Foundation’s (LAF’s)
LIVESTRONG Presidential Cancer Forum. This unique event brought together leaders
from the cancer community with presidential candidates, who presented their strategies to
combat cancer.
— Scott Hamilton
Scott Hamilton is a Member of
the Board of Directors of the
Pioneer Fund, a private family
foundation that supports
innovative organizations focused
on medical research, education,
and social welfare. Scott said
the Fund was impressed by
MMRF’s efficiency, and felt it
was an organization they could
trust to “get the job done.”
To date, the Pioneer Fund
Kathy Giusti and Lance Armstrong
has generously contributed
$4.5 million to support MMRF
research efforts.
16
17
MMRF Annual Report 2007
Raising Funds
for Research
In 2007, the MMRF hosted several successful events, raising millions of
dollars for myeloma research.
Chicago Awards Dinner
Melanie Bloom, Bob Woodruff, Jane Williams, Brian Williams,
and Lee Woodruff
May 16, 2007
Chicago, Ill.
Bob DeBaun, Scott Hamilton, Joe Damico, Bonnie Hunt, and
Lester Knight
Lance Armstrong, Nancy and Stephen Grand
“Friends for Life” Fall Gala
Oct. 27, 2007
Greenwich, Conn.
Al Heller, Scott Hamilton, Tony Kesman, and Bonnie Hunt
The MMRF’s 11th annual “Friends for Life” Fall Gala raised a recordbreaking $2.2 million and was attended by more than 1,200 people.
Founder of the Lance Armstrong Foundation, cancer survivor, and Tour de
France champion Lance Armstrong was honored with the Spirit of Hope
award and Robert Wolf, chairman and CEO of UBS Americas and Gala
Corporate Chairman, was honored the Corporate Leadership Award.
Deborah Norville, host of Inside Edition, served as Mistress of Ceremonies.
The 6th annual Chicago Awards dinner raised $700,000
for myeloma research and was attended by more than 400
people. Olympic gold medalist and cancer survivor Scott
Hamilton was honored with the Spirit of Hope award and
actor and comedienne Bonnie Hunt served as the Mistress
of Ceremonies.
Bonnie Hunt and Dr. Todd Zimmerman
18
Don and Becky Baylor
Other honored guests included Don Baylor, former MLB player/coach, and
myeloma patient; Melanie Bloom, widow of NBC news correspondent
David Bloom and national DVT patient spokesperson; Geraldine Ferraro, former
congresswoman and myeloma patient; Congressman Christopher Shays; Brian
Williams, anchor and managing editor, NBC Nightly News; and Bob and
Lee Woodruff, ABC news anchor and founder of the Bob & Lee Woodruff
Family Fund for Traumatic Brain Injury. A taped message from Senator
Barack Obama started the evening off, congratulating the night's honorees.
Karen Andrews, Robert Wolf, Kathy Giusti, and Lance Armstrong
19
MMRF Annual Report 2007
Raising Funds
for Research
Drs. Leonard Heffner and Sagar Lonial with Gaye and Tripp
Simms – Atlanta
Elizabeth Donald, Daryl and Jamey Daugherty
Kathy Giusti, Patricia and Rocky Palmer – New Canaan
Kathy Giusti, Leon Black and Fred Joseph
Races for Research
In 2007, the MMRF raised millions of dollars at 5K Race for
Research events in 12 cities. Thousands of participants, many
of them myeloma patients and their families, led the way in
helping us race toward a cure.
MMRF
RACE
FOR
RESEARCH
5K WALK/RUN
Drs. Sagar Lonial and Leonard Heffner with Chelley
Schaper – Atlanta
Feb. 7, 2007
New York, N.Y.
More than $2.3 million was raised for the MMRF and the
United Cerebral Palsy Research and Education Foundation
at the first annual Texas Hold ‘Em for Research.
Spearheaded by myeloma patient Fred Joseph, this exciting
event was chaired by Leon Black, Founder and CEO of
Apollo Management, and attended by more than 450
Wall Street executives and guests.
2007 MMRF Races for Research
Atlanta, GA
Boston, MA
Brattleboro, VT
Chicago, IL
Cleveland, OH
New Canaan, CT
Wall Street Texas Hold’ Em
for Research
Philadelphia, PA
San Francisco, CA
Seattle, WA
St. Paul, MN
Twin Cities, MN
Washington, DC
Ellie and Barry Samson, Dr. Louise Perkins
Investors Circle
Scientific Summit
Sept. 10 -11, 2007
New York, N.Y.
The MMRF hosted its third annual Investors Circle
Scientific Summit, “Accelerating Drug Development:
Progress Toward a Cure,” in New York, NY on Sept. 10-11,
2007. This exciting event brought together academia
and industry with MMRF investors to discuss research
directions and better understand the research initiatives
they are supporting.
Heather Howard and family – New Canaan
20
21
MMRF Annual Report 2007
Financials
Multiple Myeloma Research Foundation, Inc.
Statements of Activities – Years Ended December 31, 2007
and December 31, 2006
Support and Revenue
2007
2006
$ 4,319,668
9,883,02
465,846
13,695
$ 3,921,118
5,285,924
498,567
46,776
7,874,323
(1,808,862)
5,193,650
(1,201,954)
239,915
272,896
20,987,607
14,016,977
14,830,655
1,142,357
958,599
1,072,427
18,004,038
10,500,381
1,028,770
1,005,344
860,528
13,395,023
528,917
839,041
1,367,958
425,301
598,129
1,023,430
19,371,996
14,418,453
Change in net assets
1,615,611
(401,476)
Net assets, beginning of year
3,162,856
3,564,332
$4,778,467
$3,162,856
Contributions
Private foundation grants
Federal grant support
In-kind contribution
Special events
Special events support
Less special events expenses
Investment return
Total support and revenue
The MMRF 2007 Audit reported that the Foundation raised
$22.8 million, a 50 percent increase over 2006.
*Based on gross revenue
Expenses
Program
Research
Education
Awareness
Other program expenses
Total program expenses
Supporting services
Management and general
Fundraising
Total supporting services
Total expenses
Net assets, end of year
22
23
MMRF Annual Report 2007
Donors
Leadership
MMRF Leadership Council
The support of our donors has ensured that the progress we have made in multiple myeloma
will not lose its momentum. The Multiple Myeloma Research Foundation (MMRF) would
like to extend its heartfelt gratitude to all those who contributed to the MMRF in 2007.
The following pages gratefully acknowledge those generous donors from January 1, 2007
through December 31, 2007*.
Lester B. Knight
Philip J. Purcell
Robert Wolf
MMRF Board of Directors
W. Dana LaForge, Chairman
Brera Capital Partners
Stephen Grand
Grand-Sakwa Properties
William S. McKiernan
CyberSource Corporation
Kenneth C. Anderson, MD
Dana-Farber Cancer Institute
Allan Heller
Water Street Healthcare Partners
Charles B. Ortner
Proskauer Rose LLP
Karen E. Andrews
Hachette Book Group USA
Joseph M. Hogan
GE Healthcare
Robert J. Beall, PhD
Cystic Fibrosis Foundation
Frederick H. Joseph
Morgan Joseph & Company
Robert DeBaun
RoundTable Healthcare Partners
Anthony K. (Tony) Kesman
Linden LLC
Mark Fishman
Sailfish Capital Partners
Thomas J. Kipps MD, PhD
Moores UCSD Cancer Center
Kathy Giusti
MMRF
MMRC
Lori Tauber Marcus
Pepsi-Cola North America
Alan Panzer
Edward J. Phillips
Millennium Import LLC
$1 Million +
Celgene Corporation
Stephen & Nancy Grand
Avinoam Naor
$250,000 TO $999,000
Eric & Linda Emory
Millennium Pharmaceuticals, Inc.
Stuart Rosow
Proskauer Rose, LLP
Novartis
William Wilson III
Wilson Meany Sullivan LLC
Anonymous
Donna A. Zaccaro
WhatGoesAround.org
$100,000 TO $250,000
Corbett Family
Courts Foundation, Inc.
Steven and Michele Kirsch
Foundation
Morgan Joseph & Co., Inc.
Ortho Biotech
Gerald McDougall
PricewaterhouseCoopers
PDL BioPharma, Inc
Barry & Ellie Samson
Schuett Family Foundation
Serono Inc.
MMRF Honorary Board
Lance Armstrong
Bob Costas
Katie Couric
Cindy Crawford
Ann Curry
Eric Davis
Geraldine Ferraro
Scott Hamilton
Mariska Hargitay
Bonnie Hunt
Senator Kay Bailey Hutchison
Dan Jansen
Hamilton Jordan
Diana Krall
Eric McCormack
Deborah Norville
Team Continuum, Inc./
Paul Nicholls
Keith Olbermann
Sharon Osborne
General Norman Schwarzkopf
Mel Stottlemyre
Brian Williams
Paula Zahn
Tibstra Family Foundation
UBS Investment Bank
William & Pat Wilson, III
$50,000 TO $99,999
Amgen
Bank of America
Bear, Stearns & Co., Inc.
Warren & Paula Berliner
Art Bilger
Leon & Debra Black
Citigroup
24
Credit Suisse Securities
Cahill Gordon & Reindel LLP
Charles Ortner
Robert & Jane DeBaun
Carlson Family Foundation
Edward & Leslye Phillips
Deloitte Services LP
CSC Holdings, Inc.
Philip & Anne Purcell
Deutsche Bank
Joseph & Pam Damico
Realogy Corporation
Donaghue Foundation
Double H Foundation
Tony & Jamie Ressler
Elizabeth Donald
Ernst & Young
Joseph Rice
Oliver S. and Jeannie R.
Donaldson Charitable Trust
Estate of Marilyn Groveman
Leon & Cynthia Rittenberg
George & Norma Fabian
Rowan Family Foundation, Inc.
Goldman, Sachs & Co.
Brian & Allison Feltzin
J. Michael Sherrill
George & Diana Holway
First American Corporation
Kohlberg Kravis Roberts & Co.
Harry Franke
Skadden, Arps, Slate, Meagher
& Flom, LLP
KYPHON, Inc.
GE Healthcare
The Blue Oak Charitable Fund
Lehman Brothers, Inc.
Paul & Kathryn Giusti
Towerbrook Capital Partners, LP
Merrill Lynch
Go Green Self Storage/Thomas
and Gina Vaughn
Tullett Prebon
Robert & Carol Wolf
Morgan Stanley
Grosvenor Capital
Management, L.P.
David & Anne Ogilvy
Joseph & Lisa Hogan
O’Melveny & Meyers LLP
International Specialty Products
David Angliss
Rocco & Patricia Palmer
Henry Jarecki
Dean & Kimberly Assink
PriceWaterHouseCoopers
Johnson & Johnson Family
of Companies
Richard & Vicki Birdoff
Steven Joseph
Phil and Sarah Carvalho
Milken Family Foundation
Morgan Lewis & Bockius LLP
Sunesis Pharmaceuticals, Inc.
Wachtell, Lipton, Rosen & Katz
Watsco Inc.
$25,000 TO $49,999
Jefferson & Evita Allen
Anreder & Company
Aon Foundation
Apollo Management, LP
Ares Management, LLC
Ark Restaurants Corporate
Jerome Belson
Bloomberg
Brownstein, Hyatt, Farber,
Schreck P.C.
Dorothy Underwood
$15,000 TO $24,999
Richard Carter & Family
JP Morgan Securities Inc.
Cordis Corporation
Lester & Becky Knight
Laura Corwin
Latham & Watkins
Susan Davie
Thomas Lee
Katherine DeCarlo
James & Elizabeth Lee
Kenneth & Ellen Forrest
MacAndrews & Forbes
Holdings, Inc.
Fran Friedman
Al & Ruth Glancy
Jim Meekison
Global Impact
Avis Mello
Steve & Carol Goldschein
Microsoft Matching Gifts
Program
IBM
IMS Health
Lyle & Jerrie Miller
Jewish Communal Fund
Peter Moses
Kosan Biosciences, Inc.
Northern Trust
25
MMRF Annual Report 2007
Donors
Dana LaForge &
Kathleen McCabe
Morris and Gertrude Furman
Foundation
St. Vincent’s Comprehensive
Cancer Center
Robert Ciamei
Kevin & Sheri Lyons
Warner Music Group Services
Charter Management Company
John & Jan Conneely
MaHunt Corporation
Todd & Elizabeth Warnock
May Lee
Gar Advertising, Inc.
Ernest Steiner
John & Donna Culbertson
Andrew Malik
Martin & Tristen Mannion
GE Foundation, Matching Gifts
Mel & Jean Stottlemyre
Cuna Mutual Group
Lewis & Bernice Mandel
Douglas Waters &
Virginia Johnston
Chicago Title Insurance
Company
Howard Marks
Great Point Partners
Daniel K. Thorne Foundation, Inc.
Deutsche Bank
Neville & Kitty Martin
Jack & Julie McGinley
Arnold & Roberta Greenberg
Tracey Locke Partnership
William & Paula Mercer
James & Arline Greenblatt
Kelly Tschantz
Richard Davoud Donchian
Foundation
Nigro Karlin Segal & Feldstein
Hackberry Endowment Partners
Ungaretti & Harris, LLP
Pepsi Lipton Partnership
Hackensack Univ Med Center
Sapient
Paul Higbee
Choice Hotels International
Richard & Jane Hinson
Ann Wheeler-Carlson
Steven Clausen
Hochman Family Foundation, Inc.
Edward & Kathleen Maul
Keith Whiting & Betsy Colburn
Cline, Davis & Mann, Inc.
HSBC Philanthropic Programs
Frederick & Marion Whittemore
Coghill Family Foundation
Hughes Network Systems
Thomas & Marilyn Donnelly
Mayo Foundation for Medical
Education and Research
Allan Will
Jerome Cohen
Human Genome Sciences, Inc.
Ken & Beverly Vander Werf
Stanley Doobin
McGregor Fund
Williams Lea, Inc.
Jim Connelly & Scott Garrett
Infinity Discovery, Inc.
Neil & Kathleen Hamburger
Volt Information Sciences, Inc.
Richard Dvorin
Paul & Jill Meister
Wintrust Financial Corporation
Aimee Conroy
Ipswich Bank
Trust Company of the West
Henegan Construction Co., Inc.
VS Media, Inc.
Charles Ellis
Scott & Lisa Melland
Credit Renaissance Partners
Jackson & Perkins Wholesale, Inc.
Patrick & Ellen Ward
Hill and Knowlton
Michael Weiss
Epstein, Becker and Green
Merck & Co., Inc.
Paul Witteman & Eleanor
McGrath
William & Amy Curley
Julie Jeusen
Wipro Limited
Brett Himes & Annette
Severiens
Windspeed Ventures
John & Margot Ernst
Ann Moffi
Bob & Lee Woodruff
Thomas & Miriam Curnin
Jordan Industries, Inc.
Mary & Jeffrey Wirth
Richard & Lori Fernandes
Morgens Waterfall
Ira & Shirley Yohalem
JP Morgan
Martin Husby
World Wrestling Entertainment
Barry Finkelstein
Moses & Singer LLP
Abbott Laboratories
Evelyn Illich
Yahoo! Inc.
Kevin & Janice Forde
Eddie & Irma Muller
John Zaccaro & Geraldine
Ferraro
Curtis, Mallet-Prevost, Colt &
Mosle LLP
DACON
BethAnn Kaminkow
ADCO Electrical Corp
Lorraine Illich
Selig Zises
Sam & Wendy Sam Frieder
Davos Chemical Corporation
Jason & Jessica Karp
Robin Albert
Interpacific Holdings Inc.
Mark & Cindy Fuller
Newmark & Company
Real Estate
Jane Day
Stanley & Carol Kay
American Express
JLL Partners, Inc.
John & Grace Gallaway
Alexandra Papanicolaou
R. Thomas & Denise Decker
Kastory Family Foundation
Abelson-Taylor, Inc.
GE Commercial Finance
Loretta Peavey
Akrf, Inc.
Hayley Kaye
Kenneth & Cynthia Anderson
Kathleen Pellegrino
Katzen International, Inc.
Don Ackerman
GEC
Pepper Construction Group, LLC
Ronald & Toby Altman
David Kiefer
Baxter Credit Union
Mark & Heidi Dewaele
Keno Graphic Services, Inc.
Richard & Mary Adloff
Richard Goldberg
Laura Pepper-Doyle
Alvarez and Marsal
Kirkland & Ellis Foundation
BBDO NY and OMD
Eric & Laura Dobbin
Keryx Biopharmaceuticals, Inc.
Amsurg
Plaza Construction Corporation
Charles & Helen Dolan
Knight Trading Group, Inc.
Karen Andrews
Alan & Sharon Portnoi
Loreen Arbus Foundation
Stuart & Nicole Kovensky
Steven Blecher
Goldentree Asset Management,
LP
Aptium Oncology, Inc.
William Kolbert
Jeff & Tiffany Begoon
Bill Donald
Burson-Marsteller
Michael Krasny
Etta Atkin
Stanley & Pearl Goodman
Putnam Insurance Agency
Arcade Partners, LLC
Doshi Capital Partners
Mitchell Kurman & Galia
Galazan
William and Regina Butler
Valerie Krause
Quaker Foods
Josephine Arduini
Mark Dreyfus
Patricia Labriola
C.R. Bard, Inc.
Edith Baldinger Charitable Lead
Annuity Trust
Malcom & Louise Goodridge
Sanjeev Kumar & Sanjana Sahni
Michael Grant
Reed Smith, LLP
Jay Dweck
Lambda Fund Management
Cambridge Corporate Services
Midge Lefkowitz
Doug Balog
Gene & Gretchen Grisanti
Ripco Real Estate
George Backer Family
Foundation, Inc.
Wendy Langman
Alice Campbell
Robert & Lynn Lunn
Barefoot Foundation
Mark & Teri Guidi
Milton & Judith Riseman
Rand & Lynne Eyberg
Laurel Hill Capital Partners, LLC
David & Robin Carlin
McKinsey & Company, Inc.
Baxter Credit Union
GVA Williams
Rochdale Securities LLC
Thomas Graboys &
Victoria Baker
Sandor & Sue Engel
Gerald & Jane Feldman
Lehman Brothers, Inc.
Richard & Elizabeth Cashin
MidOcean Partners
Don & Rebecca Baylor
Alan & Abbe Heller
Adam & Amy Rochlin
Fidelity Charitable Gift Fund
Andrew Leven
Joseph Cassano & Ellen Hooker
Marion Moore Foundation, Inc.
Berenson, LLP
Hollister Inc.
Royal Palm Capital Partners
Grey & Anne Finn
Joyce Linde
Cbre
National Basketball Association
Sandye Berger
Michael & Randi Hopman
James & MaryJo Rushin
FlightStar, Inc.
Chris & Kay Linneman
Charles Birdoff & Co., Inc.
National Financial Services, LLC
Binding Site, Inc.
Illinois Tool Works Foundation
Elsie Sang Charitable Trust
Jay Flynn
LM Isis Capital Partners
Jason Chisholm
Newsweb Corporation
IMS Shared Business Services
Sheryl Sarnak
Fortress Investment Group
Carl & Katherine Locher, Jr.
Michael Chiusano
Opera Solutions
William Blair & Company
Foundation
J.P. Morgan Chase
Leonard Sarnat
G. Peabody & Susan Gardner
LPG Group
CIBC World Markets Corp
PepsiCo Foundation
Blavin & Company, Inc.
Heidi Kazlo Tatro
Edward & Barbara Scolnick
Gregory & Julia Gilbert
Anthony Macino & Evelyn Joyce
Todd Cooper
PGA Tour
Richard Boas
Kelso & Company
David & Jill Shulman
Earle Mack
Cooper Family Foundation
Lori Pugh-Erdle
John & Anne Boehle
A.K. Kesman Family Fund
Sierra Mist
Mark Gleason &
Nancy Rasmussen
Marge Covey
David & Stacy Purcell
John & Margaret Brewer
Jonathon & Laurie Soler
Mark & Carol Goodman
William & Gena Mann
Cushman & Wakefield, Inc.
Quorum Group of Companies
William Bron Family Fund
Knott Partners, L.P./Knott
Family Foundation
Adam Gordon
Daryl & Jamey Daugherty
R & R Mechanical
James & Joanne Brooks
Jonathan & Susan Korn
Charles Grant
Stephen Marshall &
Sandra Samberg
Donald Engel
Richard Ressler
Brookstone Homes, Inc.
Martin & Julie Gross
Richard & Sylvia Mase
Himelfarb Family
Reyes Holdings, LLC
Wally Buchband
Langan Engineering and
Environmental Services
System Parking Inc./Dennis
Quinn
GSO Capital
Jay Matola
William & Sharon Feather
Steve Rushin & Rebecca Lobo
Henry & Janne Burdick
LaSalle Bank
Claude Gwinn
Brian & Heather Mayer
The Harold and Isabel Feld
Foundation
Schwarz, Inc.
Peter Callahan
Ed & Rose Leventhal
Tennenbaum Helpern Syracuse
Hirschfritt
Frederick McCarthy
Sheffield Asset Management LLC
PJ Callahan Foundation, Inc.
Libra Securities
Toll Brothers, Inc.
Gwendolyn Halsey-Albertson
Foundation
Sidney & Francine Friedland
Russell Siebert
Canning Foundation
Samuel & Gabriele Lurie
Tyco Healthcare
Lexanne Hamilton
MEGA, Inc.
The Patricia C. and Thomas
Frist, Jr. Foundation
John Sima
Cephalon, Inc.
Michael & Cecily Lynch
US Trust
David & Audrey Hammer
Millenium Homes
Perry Snyderman
CFCNCA
Alexander Lynch
Nancy Van Leuwen
Thomas & Kristen Harrow
Kyle & Laura Miller
Matthew Spiegel
Steve Chupa
Peter & Linda Lynn
John Volgelstein
Martin & Callistheni Hayes
Monterey Fund, Inc
$10,000 TO $14,999
26
Herschend Family
Entertainment Corp.
$5,000 TO $9,999
Mark & Susan Sonnenberg
Tackle Myeloma Foundation
Heidi Zod
$2,500 TO $4,999
Jonathan & Laurie Bass
Basser-Kaufman
Shahnaz & Radford
Batmanghelidj
Leonard & Elizabeth Baum
Baxter International Foundation
Matching Gift
Benihana Inc.
Martin Berman Foundation
Judith Bernhaut
Ronald & Kathleen Bertino
Bob & Lisa Bowman
Mary Brenneis
Howard Brenner
Nelson Broms
Tom Burke
Capital Group Companies, Inc.
Charles & Nina Cardwell
Carleton Family Foundation, Inc.
Bob & Kate Carr
Chaney Progressive Club, Inc.
Lawrence & Bette Kahn
The Mahley Family Foundation
27
Bruce & Jolene McCaw
MMRF Annual Report 2007
Donors
Solon E. Summerfield
Foundation, Inc.
Bruce Barit
Peter & Lori-Ann Capitelli
Corporate Graphics
Richard & Maribeth Ellsworth
Michael & Mary Gellert
Barry & Anne Hilton
Bruce & Hilary Murray
Ashley Barit
Robert Caplan
Corporate Security Services, Inc.
Emerson Network Power
Genworth Life and Annuity Inc.
Roger Hirschhorn
Andrew & Nancy Neff
Talbots Charitable Foundation
Randolph & Deborah Barker
Carco Group Inc.
Richard Courts
Craig & Laura Emery
Georgica Advisors, LLC
John Hoegl
Network for Good
Fred & Lois Tarter
J. Patrick & Christine Barrett
Cardinal Health
Malon & Sarah Courts
Jena Engelbrecht
Bill Giessen
Christopher & Diane Hogan
Neuwirth Foundation, Inc.
John & Catherine Taylor
Janet Battaile
Nick and Susanne Carey
Lee & Marilyn Cox
Charles Engelhard Foundation
Jay Gilbreath
Christopher Hohlstein
Dave Newman
David Teiger
Jed & Elizabeth Becker
Michael Carley
Kit & Cindy Crawford
Entergy Services, Inc.
Peter Holloway
Northern New Jersey Cancer
Center
Sorin & Sheryl Teodoru
Becton Dickinson
Gregory Carlin
Morgan Crooks
EOS Foundation
GivingExpress Program from
American Express
Vera Thomas
Steven & Lorraine Bell
Robert & Antoinette Carlino
Mary Beth Crossland
Norman Epstein
Charles & Michelle Glasser
Daniel & Sarah Hooke
Matthew Olim
Sharon Thompson
Alan Belzer
Tim Carmack
Arie & Ida Crown
Ere LLP
Penny Glazier
James Hoover
Olshan Grundman Frome
Rosenzweig & Wolosky
Donna Twist
Bench International
Eric Carmichael
Kenneth & Carolyn Cruickshank
Euercore Partners
Jeff & Sheryl Goldberg
Eugene & Michael Horan
Donald Valencour
Cars4Charities
Jerry & Julia Cubbage
Leslie Fabro
Jeffrey & Susan Goldenberg
Cristina O’Meara
Bill Bennett
Rita and Larry Horn
Jerry & Kathleen Valenta
David O’Neill & Nancy Remy
Stanley & Marion Bergman
Paul & Cristine Carter
Robert & Lori Cummings
Fairview-Licht Company, LLC
Jeffrey & Helen Horowitz
Robbye Van Cleave
Pan American Capital
Partners, LLC
Robert & Libby Berner
Charles & Catherine Carter
Ken & Helen Curtis
Philip & Barbara Falkowitz
Brian Goldman &
Melissa Marshal
C. George Van Kampen
Foundation
Robert & Brenda Berry
Chip Carver
CVS/Caremark RX Inc
Jim & Adrianne Fauci
James Gordon
Albert & Sandra Huntington
Louis & Laura Pels
Ceci Brothers Inc.
D.E.W. Company
Elinor Feiss
Petunia Productions
Wachovia Sec.– Meranze Privat
Wealth Advisory
Brian & Heiji Black
CEO Connection
Nicholas & Eileen D’Agostino
Robert Feldman
Wagner Family Foundation
John & Faye Chaplin
D’agostino Landscaping
Mary Feloney
Shulamith Grauman
Phileona Foundation
John Blackburn &
Connie Lindsey
Michael Warren
Chris Daley
Gerald & Eleanor Weinstein
Donal (Jack) & Fran Daley
Financial Industry Technical
Services, Inc.
Lloyd Green
Milton & Elinore Povill
Charter Realty &
Development Corp
Great Capital
Robert Piccone
Charmaine Blatt
Western Washington Chapter
Mark & Kathryn Chelsky
Dana Farber Cancer Institute
Jeffrey Fink
Grey Global Group, Inc.
Harold & Donna Purkey
Blumenfeld Devleopment
Group
Whitney Group
Michael & Dina Fink
Eugene Blumenthal
Rufus & Maybell Darden
Robert & Barbara Griffith
Quad-C Management, Inc.
Harry & Ann Chess
Brian & Jane Williams
Judith Finley
Arnold Bodmer
Brad & Lisa Davidoff
Sean & Jacqueline Griffiths
Renaissance Charitable
Foundation, Inc.
Gregory & Robin Chess
Finnegan Family Foundation
Gene & Tracy Rigo
Michael Bolin
Franklin Davidson
Michael & Nancy Grogan
Marilyn Willis
Jeff Chester
The Ritchey Family Community
Property
Michael Bolling
Gareth Davies
Don Wilson
Steven Chronert
Boston Foundation
Evan & Mary Davis
First County Bank
Foundation, Inc.
Karen Grossman
David & Alexa Willson
David & Debbie Chizewer
William Grow
Roberts & Holland LLP
Ken & Marianne Bouldin
DDB Worldwide
Communications Group, Inc.
First United Bank
Walter Wilson & Elizabeth
Lenore Wilson
Christopher & Julie Ellen
Church
Helge & Cathy Fischer
Harry Gruszecki
Lindsay Rosenwald
WMY Fund
Aryeh Bourkoff
Patricia Cicchella
Fred Deandrea
Peter Fisher
Kenn & Lana Guernsey
Alfred & Eileen Rossi
Wolfensohn Family Foundation
Sherman & Carole Boxer
Charles & Allison Clarke
John & Gayle DeBaun
Stephanie Fitch
Jeffrey Gural
Savoy Capital, Inc.
John & Anne Zaccaro, Jr.
Kim Bozzella
Clayton Family Fund
Tony Decello
James E. Fitzgerald, Inc.
Richard & Doris Gurtler
Marjorie Schad
Marcia Zisselman
Ruth Brause
Thomas & Kathleen Cleary
Demoulas Foundation
William & Anne Flanagan
Joseph & Sheila Gutman
Mike & Heather Brennan
Bob Cline
Joseph & Debbie DeNicola
Ninetta Fleming
Walter Hamilton
Richard & Ellen Breslaw
Jerome & Carol Coben
Herman & Henrietta Denzler
Forest Hills Financial Group
Bruce Briney
Rochelle Cohen
Foster Devereux
Linda Britt-Cole
Adam Cohen & Jeanne Lurie
Matthew & Theresa Brogan
Collineo Asset Managemment
USA, Inc.
Robert Diamond &
Ilene Gerstein
Giuseppi Forgione Revocable
Living Trust
John & Cathleen
Hammerschlag
Michael & Linda Morris
John Schmuck
Securitas Security Services
USA Inc.
Select Investment Realty
Advisors
Semafore Pharmaceuticals
SESAC, Inc.
Pamela Shiells
Marc Silberberg
Harvey Silverman
Barry & Bonnie Singer
Richard Sinn
Joel & Joan Smilow
Edward Smith
Matthew Sosnik
Matthew Stedman
28
$1,000 TO $2,499
Ernest & Barbara Abate
Richard Acherman
Lisa Adams
Ades Foundation
Jeffrey & Carol Blum
Michael & Debby Brooks
Allen Horwich
Adam & Alicia Grabow
Husch & Eppenberger, LLC
Phil & Wendy Gramm
Richard & Sandra Hutson
Alice Impraim
Shawn Ingall
Insearch Worldwide Corporation
Milton Irvin
Scott Isherwood
Ivy Asset Management
David & Robin Jacobs
Alan & Barbara Jacobs
Robert Grossman
Chad & Karen Jacobs
David & Helen Jaffe
Maarten Jager
Robert & Margaret Jakacki
Jaros Baum & Bolles
Timothy & Susan Jensen
Beverly Johnson
David Johnson
Judy Johnson
Handelsman Family Foundation
Para Family Foundation
Margaret Happel
Betty Dickson
Andrew Fox
Doug Harmon
Avram & Rhoda Freedberg
Robert Hart
Arthur & Sari Agatston
Alvin & Barbara Dischler
R. Craig & Kirsten Collister
Jeffrey & Rosalind Freidus
Scott Hartman
Jack M. Aiello
W. Thomas Dixon
Jane Brown
Community Banks Foundation
Barry & Stacie Friedman
Ed & Nancy Hawfield
Alliance Bernstein, LP
Bill Donan
Leonard & H. Joanne Brumberg
Laura Conlon
Craig Frischling
Sigi & W.E. Hays
Allied Advertising Agency
Dubin Paper Co.
Alan Brumberger
Tom & Vivian Duncan
Alan Frost
Hecht and Company Pc
America’s Charities Distribution
Account
Thomas Bubeck
Considine Sales &
Marketing, Inc.
Steve & Susan Frushtick
David Hedley
Sam & Kathy Anderson
Burberry
Continuum Health, LLC
Geoffrey Dunn
Robert Frye
Ronald Hedlund
Clyde Burch
Cynthia Converse
Dawn Duquaine
Jesse Furman & Ariela Dubler
Thomas Heftler
Garry Burns
Ron Conway
Dyson-Kissner-Moran
Corporation
Furst Foundation, Inc.
David Helfand
David & Carey Burwick
Cook-Blackiston, LLC
Mark N. Edoff
John & Susan Gainer
Robert & Jacqueline Helpern
Byrne Dairy, Inc.
Cooper-Horowitz
Mark & Sandy Ehlert
Joe & Kathleen Gallichio
Robert Herzberg
Carlos & Olga Luisa Camargo
Corestaff Support Services, Inc.
Bill & Suzanne Einstein
Edward Gannon
Rodger Hess
Matthew Campbell
Corinthian Capital Group, LLC
Richard Eisenberg
Wilbur & Linda Gantz
Hewitt Associates
Jean Campbell
Corn Products Inc.
Eisner, LLP
Philippe Gauthier
Janet Hill
Bette Stein
Archer Daniels Midland
Company
Stephens Inc.
Rod & Kathleen Armstrong
Structural Graphics
Susan Solomon Auerback
David Justice & Pamela Tate
Neil Katz
John Collins Engineering
Peter Arbeiter
B. Frank Joy, LLC
David Kaplan
Charles Brooks &
Suzan Bramson
Anonymous
Howard & Lois Honigfeld
Harry & Sue Kavetas
Garnett Keith
Debra Kennedy
Kenneth Cole Productions, Inc.
Robert & Dawn Kern
Jasper Kids
John & Patricia King
Janet King
Michael & Margery Kirsch
John & Barbara Kleylein
Christinie Knox
David & Lesly Koo
Richard & Claire Korn
Ken & Lisa Kornblau
29
MMRF Annual Report 2007
Donors
Alan & Judith Kosloff
John MacFarlane
Melissa Russell
Raymond & Julie Soffientini
George & Sharon Thompson
Westbrook Development
Mack Trucks Sales
Jonathan Mothner &
Eve Konstan
Steven & Juliet Plonsker
Earl Kostrow
Olivia Lee Pollock
Donna Russo
Mark & Bill Sokolis
Chris Thompson
E.A. & Teresa Kratzman
Louise Madden
Thomas & Joan Moverman
Gary & Felice Povill
Skip & Cathy Russo
David Solomon
Westerman, Ball, Ederer, Miller
& Sharfstein
James Kuhn
Joe & Susan Madonia
Scott Prince
Christopher Ryan
Elizabeth Sandra Sondak
Milton & Henrietta Kushkin
Linda Maguire
George & Zula
Crichton-Brigham
Thompson, Becker &
Bothwell, LLC
Amaury Rzad
Sony Pictures Entertainment
Thrivent Maine Chapter
Forrest & Kathleen Whittaker
Thomas & Stephanie Kushner
Robert Mandy
George & Claire Speen
Charles Thurnher
Larry Whittemore
Sheldon & Keri Manhein
Professional Boiler
Maintenance, Inc.
SAKS Fifth Avenue
Andrew Kuzneski
Mt. Diablo Investment
Group, LLC
Greg & Lorraine Pritchard
Katherine Samuels
Arnold & Linda Spellun
Donald & Cynthia Wieneke
Veronica Kwan-Rubinek
Connie Maniatty
Stephen Prough
Jordan Saper & Jill Rittmaster
Gianni & Clare Spera
Neal Tiemann &
Joy Zucker-Tiemann
Robert & Eugenia Labbancz
James & Lori Marcus
Joseph & Elaine Tighe
Mark & Lemoy Muller
Joseph & Janice Willett
Julie & Beau Marcus
Nicholas Tiller
Morris & Ruth Williams
Marta Lawrence
Ed and Barbara Markham
Steve & Mary Murdock
Sara Lee Foundation
Matching Gifts
St. Cloud Capital
Eric Larson & B. Wu
Prudential Foundation
Matching Gifts
John & Suzanne Prunier
Carol Williams
Leader Jet
Robert & Jean Markley
Diane & John Prunotto
Catherine Staib
Hollis & Dorothy Tinsler
Mike Murphy
Todd Saunders
Roy Wilschut
Leading Edge Turbine
Technologies, Ltd.
Carl Martignetti
Quaker Oats Company
James & Carolyn Stauner
Albert Tone
Peter Murphy
Bill & Pamela Saxelby
Robert Murray
Richard & Linda Schaps
Matthew Murray
Arielle Schechter
Theresa Quinn
Jaimie & Esta Stecher
Snarkes Same &
Louise Tootalian
Peter Wilson
Paul & Anne-Marie Queally
Warren & Jane Stebbins
Barry & Karen Wolf
Gustav Raaum
Sidney & Bertha Stein
Ulrik & Julia Trampe
Sal & Christina Naro
Gabriele Schmitt
Mildred Nash
John & Arnold Schmitt
Grace Rapinchuk
Janet Steiner
National Amusements, Inc.
Lewis Schneider
Rapp Collins Worldwide
Sterling Properties
National City Bank
Ellen & Kirk Schubert
RBS Greenwich Capital
John Stiles
John Neal
Ken Schuepbach
Paul & Kathy Reading
Michael Stone
Doug & Linda Neilsson
Edward Schwartz
Jason & Christine Reese
Jonathan & Patricia Strain
Todd Nelmark
Donna Schwarzbach
John & Donna Regan
Strategic Frameworking
Diane Nelson
David Seidler
Craig & Melissa Reiff
Bryan & Leslie Street
Everette Newman
James Shaw
James & Heidi Reilly
Steven & Nancy Streit
Richard & Anne Nicholls
Ellen Shear
Marvin & Susan Reiss
Sun Trading LLC
Stephen & Kimberly Niggeman
Elissa Shriener
Maurice Reissman
David Sussman
NiSource
Ami Shrimankar
Charles & Teresa Ressel
Lois Svard
David & Pamela Norton
Mike Shullman
Restaurant Associates
Joseph & Myrtle Nunn
David & Patricia Sias
Stanley Swete & Madonna
Manley Swete
Jeanne Reynolds
Ocean Partners USA, Inc.
Richard & Gail Siegal
T W Perry
Lawrence & Leonora Reynolds
William & Katie O’Connor
Leonard & Blanche Siegel
Gary & Louise Takata
Victor Rich
James & Colleen O’Connor
Phillip & Veronica Siegel
Tanenbaum-Harbor Co., Inc.
Richard and Jewel May Fund
William Ogden
Sign Tech International, Inc.
Douglas Tansill
Seymour Richman
Olde Atlanta Recycling
Roger & Linda Sisterman
Jeffrey & Anne Riskin
James Oliviero
Steven & Meryl Sitver
Laszlo N. Tauber Family
Foundation
River Cats Foundation, Inc.
Temple University Health System
Omega Overseas Investments
John & Mary Skelly
Michael Robertson
Fern Tessler
Fran Waring
Margaret O’Neill
Saul Skoler
Dana & Lucy Robin
Rockborn Trucking & Excavation
Steve & Becky Watson
Karen Orzechowski
David & Cathy Slack
The Gary & Bernice Lebbin
Foundation, Inc.
Jon & Button Watkins
Michael Orscheln
Skyline Hotel Llc
Robert Rome
The Private Bank
John & Lesley Osborn
Barbara Smith
Rosenbaum Design Group
The Strauss Hawkins Fund
Luke Osborne
Jeffrey Smith
Weed & Duryea Lumber and
Home Center
Neal & Michele Rosenberg
Lawrence & Michelle
Snyderman Platt
George Weiss
Michael Palladino
Dina Faith Rosenberg
Foundation
Theodore & Renee Weiler
Foundation, Inc.
Peter & Deborah Weinberg
Pamela Owen
Alfred Smith
Richard Wells
William Parker
Joshua & Amy Rosenow
John & Iola Sobeck
John Thoma & Kathleen
Cummings
Robert Morefield
Dixon Parker
Wendy Ross
Steven Roth
Gerald & Kay Luff
Vernon Morris & Karen
Bishop Morris
Amnoh & Anne Parlzat
Eric Paulson
Jeff & Jacquie Rothe
Pamela Lunny
Virginia Morrissette
Peach Tree Transportation, Inc.
Roundtable Healthcare Partners
Bruce Lyman
Richard Morrow
Clayton & Kristina Peavey
Marc Rozman
John & Marjorie Lyons
Jesse Morton
Mark & Stephanie Perezous
Ruger Chemical Co., Inc.
Paula Maccabee
Kevin & Dana Morton
Tyler Phillips
John & Stephanie Rushin
Robert & Jeanette Leaf
Kenneth D. Martin and
Associates, LLC
Leahy Family Foundation
Edward Massaro
Louise Leatherdale
Helen May
Philip & Susan Lebowitz
Marc & Nora Mazur
Richard Lee
James & Cheryl McCarthy
Clarissa Lefkowitz
McCarty Associates
Daniel & Sandra Leib
Charles McDaniel
Jules & Mimi Leibman
Paul & Carol McDermott
Robert & Jackie Leonard
Catherine Michele McHugh
Leonard Jackson Associates
N. McInnis
Michael Lerner
Jeff & Patricia McMahan
Jerry & Carol Levin
William & Janice Mears
Adam Levinson &
Brittany O’Neil
Mediavest
Joan & Avery Levy
Noah Levy
Brian & Sharon Libman
Ann Meschery
Metropolitan National Bank
John Michaely
Jacob Lichy
Tryggre & Tina Mikkelsen
Michael & Pamela Liebman
Krouse
Clarissa Milano
William & Annette Lifford
Joshua Miller
Jim Lilinsky
Rob Lindner
Robert Linton
Robert & Eileen Lipman
Lil Lockman
Sanford Loewentheil
Richard Lombard
Dennis Love & Betts Culp
Mitchell & Ann Lowenthal
Mary Lowry
Loyola University Medical Center
30
David Melian
Steven & Linda Miller
Eric & Susan Miller
Charles Mills
Martin & Mendelle Milston
Vincent Mistretta
MLH Capital LLC
Irvin Modlin
Fran Molinari
Mona Dabbon Focus Data
Craig Moncher
MTN Capital Partners
Daniel & Elisabeth Mulhern
St. Helena Rotary Club
Thomas & Lois White
Clarence & Lara Wildeboer
Donald & Patricia Winey
Brian & Emma Tucker
John Wolf
Unconventional Events
Pierre & Deborah Wolf
Jacob Underhill
Ken Yacobozzi
John & Donna Underwood
Carol Yanow
Unified Growth Partners
Yassky Properties
University of Chicago
Medical Center
Dianne Young
Donald Young
Mark Urich
Elisse Young
Jim & Joy Utts
Charleeton & Sandra Younts
Valerie Ann Luff Foundation
Jeffrey Yundt
James & Christine Venuti
Reg Vitek
Jeremy & Melody Vogelmann
H. Kurt & Deirdre von Moltke
Nancy Wadhams
Donna Zaccaro &
Paul Ullman
Anne Zaczek
Dennis Zaslavsky
Zenner Consulting Group, LLC
Lisa Wadler
Carl Wagner
Zevenbergen Capital
Investments, Inc.
Barbara Walder
Ziopharm Oncology, Inc.
Sanford & Bernice Waldman
Peter Walsh
Edward & Rita Werger
The MMRF is grateful for every donation it receives. However, due to space limitations, this
list reflects donors who have contributed $1,000 or more.
31
MMRF Annual Report 2007
32
MMR-093 L 7/30
Multiple Myeloma Research Foundation
383 Main Avenue
MerrittView – 5th Floor
Norwalk, CT 06851
Ph: (203) 229-0464
Fx: (203) 229-0572
E-mail: [email protected]
www.multiplemyeloma.org
3:40 pm